User talk:Rakshak pharma

ACERAK-SP a fixed-dose combination of aceclofenac 100 mg, paracetamol 500 mg and serratiopeptidase 15 mg. This combination offers the advantage of the peripheral effects of aceclofenac, the central effect of paracetamol and pain relief with the tissue repair effects of serratiopeptidase for pain management.

Aceclofenac is an orally administered phenylacetic acid derivative with effects on a variety of inflammatory mediators. Through its analgesic and anti-inflammatory properties, aceclofenac provides symptomatic relief in a variety of painful conditions. Due to its preferential cyclooxygenase (COX-2) blockade, it has better safety than conventional non-steroidal anti-inflammatory drugs (NSAIDs) with respect to adverse effects on the gastrointestinal and cardiovascular system.

Paracetamol acts predominantly by inhibiting prostaglandin synthesis in the central nervous system and, to a lesser extent, through a peripheral action by blocking pain impulse generation. Paracetamol is one of the effective mild analgesics, suitable for treating mild-to-moderate pain.

Serratiopeptidase breaks down fibrin, which is believed to be one of the causes of chronic inflammation. It also causes thinning of the fluids in the body as a result of injury, making fluid drainage smoother. It can break down protein and facilitate fibrinolytic activity in the blood, and modify molecules that guide inflammatory cells to their targets. This activity includes the digestion of scar tissue, blood clots, cysts, mucus, arterial plaque, and all types of inflammation. Serratiopeptidase reduces internal tissue oedema and inflammation caused at post-operating handling. It can also block the pain-inducing amines from swollen tissues.

Welcome!
Hello, Rakshak pharma, and welcome to Wikipedia! I hope you like the place and decide to stay. Unfortunately, one or more of the pages you created, such as User:Rakshak pharma, may not conform to some of Wikipedia's content policies and may not be retained. In short, the topic of an article must be notable and have already been the subject of publication by reliable and independent sources.

Please review Your first article for an overview of the article creation process. The Article Wizard is available to help you create an article, where it will be reviewed and considered for publication. For information on how to request a new article that can be created by someone else, see Requested articles. If you are stuck, come to the Teahouse, where experienced Wikipedians can help you through the processes.

New to Wikipedia? Please consider taking a look at the our introductory tutorial or reviewing the contributing to Wikipedia page to learn the basics about editing. Below are a few other good pages about article creation.
 * Article development
 * Standard layout
 * Lead section
 * How to write a great article
 * The perfect article

I hope you enjoy editing here and being a Wikipedian! Please sign your name on talk pages using four tildes ( ~ ); this will automatically produce your name and the date. If you have any questions ask me on my talk page or you can just type help me on this page, followed by your question, and someone will show up shortly to answer your questions. Again, welcome! Ashley yoursmile!  08:23, 8 January 2021 (UTC)

Speedy deletion nomination of User:Rakshak pharma


A tag has been placed on your user page, User:Rakshak pharma, requesting that it be speedily deleted from Wikipedia. This has been done under section G11 of the criteria for speedy deletion, because the page appears to be advertising which only promotes or publicises someone or something. Promotional editing of any kind is not permitted, whether it be promotion of a person, company, product, group, service, belief, or anything else. This is a violation of our policies regarding acceptable use of user pages — user pages are intended for active editors of Wikipedia to communicate with one another as part of the process of creating encyclopedic content, and should not be mistaken for free webhosting resources or advertising space. Please read the guidelines on spam, the guidelines on user pages, and, especially, our FAQ for Organizations.

If you think this page should not be deleted for this reason, you may contest the nomination by visiting the page and clicking the button labelled "Contest this speedy deletion". This will give you the opportunity to explain why you believe the page should not be deleted. However, be aware that once a page is tagged for speedy deletion, it may be deleted without delay. Please do not remove the speedy deletion tag from the page yourself, but do not hesitate to add information in line with Wikipedia's policies and guidelines. If the page is deleted, and you wish to retrieve the deleted material for future reference or improvement, then please contact the. Ashley yoursmile!  08:23, 8 January 2021 (UTC)

ACERAK-SP
Hepatotoxicity Taking more than daily dose of Paracetamol may cause serious liver damage or allergic reactions (eg. swelling of the face, mouth and throat, difficulty in breathing, itching or rash). Most of the cases of liver injury are associated with the use of paracetamol at doses that exceed 4,000 mg per day. (See WARNINGS AND PRECAUTIONS) Rakshak pharma (talk) 08:43, 8 January 2021 (UTC)

ACERAK-SP composition
Each film-coated tablet contains: Aceclofenac, IP …...100 mg Paracetamol, IP …......... 325 mg Serratiopeptidase, IP …..........15 mg eg. to enzyme activity of 30,000 units (as enteric-coated granules) Rakshak pharma (talk) 08:44, 8 January 2021 (UTC)

ACERAK-SP dosage form
Tablet for oral use Rakshak pharma (talk) 08:46, 8 January 2021 (UTC)

Description
ACERAK-SP is a fixed-dose combination of aceclofenac 100 mg, paracetamol 500 mg and serratiopeptidase 15 mg. This combination offers the advantage of the peripheral effects of aceclofenac, the central effect of paracetamol and pain relief with the tissue repair effects of serratiopeptidase for pain management.

Aceclofenac is an orally administered phenylacetic acid derivative with effects on a variety of inflammatory mediators. Through its analgesic and anti-inflammatory properties, aceclofenac provides symptomatic relief in a variety of painful conditions. Due to its preferential cyclooxygenase (COX-2) blockade, it has better safety than conventional non-steroidal anti-inflammatory drugs (NSAIDs) with respect to adverse effects on the gastrointestinal and cardiovascular system.

Paracetamol acts predominantly by inhibiting prostaglandin synthesis in the central nervous system and, to a lesser extent, through a peripheral action by blocking pain impulse generation. Paracetamol is one of the effective mild analgesics, suitable for treating mild-to-moderate pain.

Serratiopeptidase breaks down fibrin, which is believed to be one of the causes of chronic inflammation. It also causes thinning of the fluids in the body as a result of injury, making fluid drainage smoother. It can break down protein and facilitate fibrinolytic activity in the blood, and modify molecules that guide inflammatory cells to their targets. This activity includes the digestion of scar tissue, blood clots, cysts, mucus, arterial plaque, and all types of inflammation. Serratiopeptidase reduces internal tissue oedema and inflammation caused at post-operating handling. It can also block the pain-inducing amines from swollen tissues. Rakshak pharma (talk) 08:48, 8 January 2021 (UTC)

January 2021
 Your account has been blocked indefinitely from editing because of the following problems: the account has been used for advertising or promotion, which is contrary to the purpose of Wikipedia, and your username indicates that the account represents a business or other organisation or group or a web site, which is against the username policy.

You may request a change of name and unblock if you intend to make useful contributions other than promoting your business or organization. To do this, first search Special:CentralAuth for available usernames that comply with the username policy. Once you have found an acceptable username, post the text at the bottom of your talk page. Replace the text "Your proposed new username" with your new username and replace the text "Your reason here" with your reasons to be unblocked. In your reasons, you must:
 * Disclose any compensation you may receive for your contributions in accordance with the Paid-contribution disclosure requirement.
 * Convince us that you understand the reason for your block and that you will not repeat the kind of edits for which you were blocked.
 * Describe in general terms the contributions that you intend to make if you are unblocked.

Appeals: If, after reviewing the guide to appealing blocks you believe this block was made in error, you may appeal it by adding the text at the bottom of your talk page. Replace the text "Your reason here" with the reasons you believe the block was an error, and publish the page. —  Newslinger  talk   09:05, 8 January 2021 (UTC)